Javascript must be enabled to continue!
Inducible nitric oxide synthase inhibitors: A comprehensive update
View through CrossRef
Abstract
Inducible nitric oxide synthase (iNOS), which is expressed in response to bacterial/proinflammatory stimuli, generates nitric oxide (NO) that provides cytoprotection. Overexpression of iNOS increases the levels of NO, and this increased NO level is implicated in pathophysiology of complex multifactorial diseases like Parkinson's disease, Alzheimer's disease, multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease. Selective inhibition of iNOS is an effective approach in treatment of such complex diseases.
l
‐Arginine, being a substrate for iNOS, is the natural lead to develop iNOS inhibitors. More than 200 research reports on development of nitric oxide synthase inhibitors by different research groups across the globe have appeared in literature so far. The first review on iNOS, in 2002, discussed the iNOS inhibitors under two classes that is, amino acid and non‐amino acid derivatives. Other review articles discussing specific chemical classes of iNOS inhibitors also appeared during last decade. In the present review, all reports on both natural and synthetic iNOS inhibitors, published 2002 onwards, are studied, classified, and discussed to provide comprehensive information on iNOS inhibitors. The synthetic inhibitors are broadly classified into two categories that is, arginine and non‐arginine analogs. The latter are further classified into amidines, five‐ or six‐membered heterocyclics, fused cyclics, steroidal type, and chalcones analogs. Structures of the most/significantly potent compounds from each report are provided to know the functional groups important for incurring iNOS inhibitory activity and selectivity. This review is aimed to provide a comprehensive view to the medicinal chemists for rational designing of novel and potent iNOS inhibitors.
Title: Inducible nitric oxide synthase inhibitors: A comprehensive update
Description:
Abstract
Inducible nitric oxide synthase (iNOS), which is expressed in response to bacterial/proinflammatory stimuli, generates nitric oxide (NO) that provides cytoprotection.
Overexpression of iNOS increases the levels of NO, and this increased NO level is implicated in pathophysiology of complex multifactorial diseases like Parkinson's disease, Alzheimer's disease, multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease.
Selective inhibition of iNOS is an effective approach in treatment of such complex diseases.
l
‐Arginine, being a substrate for iNOS, is the natural lead to develop iNOS inhibitors.
More than 200 research reports on development of nitric oxide synthase inhibitors by different research groups across the globe have appeared in literature so far.
The first review on iNOS, in 2002, discussed the iNOS inhibitors under two classes that is, amino acid and non‐amino acid derivatives.
Other review articles discussing specific chemical classes of iNOS inhibitors also appeared during last decade.
In the present review, all reports on both natural and synthetic iNOS inhibitors, published 2002 onwards, are studied, classified, and discussed to provide comprehensive information on iNOS inhibitors.
The synthetic inhibitors are broadly classified into two categories that is, arginine and non‐arginine analogs.
The latter are further classified into amidines, five‐ or six‐membered heterocyclics, fused cyclics, steroidal type, and chalcones analogs.
Structures of the most/significantly potent compounds from each report are provided to know the functional groups important for incurring iNOS inhibitory activity and selectivity.
This review is aimed to provide a comprehensive view to the medicinal chemists for rational designing of novel and potent iNOS inhibitors.
Related Results
Assessment of Nitric Oxide Synthase Protein Level in the Scalp of Androgenetic Alopecia
Assessment of Nitric Oxide Synthase Protein Level in the Scalp of Androgenetic Alopecia
Abstract
Background
Androgenetic alopecia (AGA) is the most common form of hair loss in males due to excessive response t...
Induction of hepatic ito cell nitric oxide production after acute endotoxemia
Induction of hepatic ito cell nitric oxide production after acute endotoxemia
Nitric oxide is a highly reactive mediator released in the liver by hepatocytes, Kupffer cells and endothelial cells during endotoxin-induced inflammation. In this study we determi...
Nitric Oxide Pathways in Toxic Responses
Nitric Oxide Pathways in Toxic Responses
AbstractThe host response to chemically induced tissue injury is complex, involving a variety of cell types and soluble mediators. One of the most intensely investigated mediators ...
Targeting the ATP Synthase in Staphylococcus aureus Small Colony Variants, Streptococcus pyogenes and Pathogenic Fungi
Targeting the ATP Synthase in Staphylococcus aureus Small Colony Variants, Streptococcus pyogenes and Pathogenic Fungi
The ATP synthase has been validated as a druggable target with the approval of the ATP synthase inhibitor, bedaquiline, for treatment of drug-resistant Mycobacterium tuberculosis, ...
Nitric Oxide Protects Murine Embryonic Liver Cells (BNL CL.2) from Cytotoxicity Induced by Glucose Deprivation
Nitric Oxide Protects Murine Embryonic Liver Cells (BNL CL.2) from Cytotoxicity Induced by Glucose Deprivation
Abstract:We investigated the protective effects of nitric oxide on cell death of murine embryonic liver cells (BNL CL.2) after glucose deprivation. Endogenous nitric oxide producti...
Effect of endothelin-1 on endothelium-derived vascular responsiveness in man
Effect of endothelin-1 on endothelium-derived vascular responsiveness in man
1.Endothelium-dependent vasodilatation via nitric oxide in response to muscarinic stimulation is decreased in chronic heart failure while basal release of nitric oxide may be incre...
Effect of Nitric Oxide Synthase Inhibitors on Lipid Peroxide Formation in Liver Caused by Endotoxin Challenge
Effect of Nitric Oxide Synthase Inhibitors on Lipid Peroxide Formation in Liver Caused by Endotoxin Challenge
Abstract:This study investigated the effect of nitric oxide on lipid peroxide formation during endotoxaemia. Nitric oxide synthase inhibitors NG‐monomethyl‐L‐arginine acetate (L‐NM...
Interplay of Thyroid hormones, Nitric oxide and Nitric oxide synthase in Potentiating the Breast Cancer metastasis
Interplay of Thyroid hormones, Nitric oxide and Nitric oxide synthase in Potentiating the Breast Cancer metastasis
Background: Thyroid hormones are able to induce proliferation of breast cancer(BC) cells and these growth promoting effects were similar to estrogen suggesting a significant small ...

